Faeth Therapeutics, Inc. (FTH) Free cash flow 2020–2025
Faeth Therapeutics, Inc. (FTH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$20.5MFY2025 · since FY2020: -$18.9M → -$20.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.5M | +17.5% |
| FY2024 | -$24.8M | +22.9% |
| FY2023 | -$32.2M | +18.2% |
| FY2022 | -$39.3M | -21.9% |
| FY2021 | -$32.3M | -70.7% |
| FY2020 | -$18.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice